GENE ONLINE|News &
Opinion
Blog

AbbVie
AbbVie Boosts Global Manufacturing with $223 Million Expansion in Singapore
2024-01-29
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Dutch Pharmaceutical Watchdog Organization Sues Abbvie over Humira Pricing
2023-02-22
AbbVie and Genmab’s Joint Cancer Treatment Receives EMA Validation
2022-10-28
AbbVie Buys DJS Antibodies For $255 Million To Beef Up Immunology Portfolio
2022-10-21
New Data Shows the Long Term Effectiveness of AbbVie’s Psoriatic Arthritis Treatment
2022-09-12
Sosei Heptares and Abbvie Partner in Potential $1.2 Billion Neurological Disease Deal
2022-08-02
AbbVie Scores First FDA Thumbs Up for Crohn’s Disease
2022-06-20
AbbVie & Cugene Join Forces to Tackle Autoimmune Diseases
2022-05-17
AbbVie’s Big Moves; Expanding with One Company, Cutting Ties with Another
2022-04-21
Compensating for OxyContin: The Harm from Pharma
2022-04-12
How Did the Russian Invasion of Ukraine Affect Global Biopharma?
2022-03-16
Abbvie Acquires Neuroscience Company Syndesi for $1 Billion
2022-03-02
The Next SuperStar Drug? AbbVie Places its Hope on Skyrizi and Rinvoq
2022-02-16
1 2
LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top